Crepey, Sagging Skin After Menopause: What the Collagen Research Shows

Why does skin get crepey and saggy after menopause?

Crepey skin is not just thin skin. It is skin that has lost the dense, interwoven collagen and elastin scaffolding that normally holds it taut against gravity, leaving a surface that looks finely wrinkled, like crepe paper, and folds rather than springs back when pinched.

The landmark data on how much is lost, and when, comes from Brincat and colleagues, who biopsied the skin of untreated postmenopausal women and found collagen content fell fastest in the first 5 years after periods stopped. A separate study by Shuster and colleagues established the baseline most people never hear about, skin collagen already declines by roughly 1% a year starting in the twenties. That means the menopausal drop is not the beginning of skin aging. It is a sharp acceleration of something that had been happening slowly for decades.

The two proteins losing their biggest supporter

Two structural proteins do almost all of the work of keeping skin firm and bouncy:

• Collagen, mostly types I and III, forms the dense mesh that gives skin its tensile strength, the reason it does not tear or sag under normal stress
• Elastin, a separate protein, is what lets skin snap back into place after being stretched or pinched
• Collagen fibers get thinner and more disorganized as production slows, instead of running in the tight parallel bundles seen in younger skin
• Blood vessel density in the skin drops at the same time, which matters because fibroblasts, the cells that manufacture collagen, need a blood supply to do that work
• Fat and muscle beneath the skin also thin with age, removing the underlying support structure that used to hold the collagen layer taut

Every one of those changes points back to the same upstream signal. That signal is estrogen.

What does estrogen actually have to do with skin collagen?

Skin fibroblasts, the cells that build collagen, carry estrogen receptors directly on their surface. A 1999 study by Affinito and colleagues, comparing skin biopsies from premenopausal and postmenopausal women, concluded plainly that "the decrease of skin collagen is an estrogen-related phenomenon." That is not a hedge. It is the authors' own stated conclusion.

A 2013 review by Thornton laid out the mechanism in more detail, published in the journal Dermato-Endocrinology. The paper states plainly, "Estrogen insufficiency decreases defense against oxidative stress; skin becomes thinner with less collagen, decreased elasticity, increased wrinkling, increased dryness and reduced vascularity." That single sentence covers nearly every visible sign women report after menopause, in skin that has simply stopped getting the hormonal instruction to maintain itself at the same rate.

A 1994 study by Castelo-Branco and colleagues, biopsying 76 women's abdominal skin alongside their bone density, found something that rarely makes it into skincare marketing. Collagen loss in skin correlated with bone mass loss in the same women (r = 0.586, a strong statistical relationship). The authors were careful to say this does not prove osteoporosis is a collagen disorder, that remains unproven, but the finding shows the skin you see in the mirror and the bone density you cannot see are falling on a related timeline, in the same body, for a related reason. For more on that bone side specifically, see Optimum's shilajit osteoporosis clinical trial breakdown and the shilajit bone research hub.

None of this means nothing can be done. It means whatever is done has to work on the actual mechanism, not just the surface.

Has shilajit been tested on skin collagen in women?

Yes, in one real human trial, and the honest limits of that trial matter as much as the result. A 2019 randomized, placebo-controlled study led by Das and colleagues gave 45 women either a placebo or shilajit at 125 mg or 250 mg twice a day for 14 weeks, with skin biopsies taken at week 2 and week 14.

The findings were specific:

• At the 250 mg twice-daily dose, shilajit improved skin blood perfusion compared to both baseline and placebo, visible as increased reddish coloration on dermascopic imaging
• Three separate collagen genes were switched on at both doses tested: COL1A1, COL5A2, and COL14A1
• A set of genes tied to blood vessel growth and endothelial migration were also induced, through pathways called VEGFA and TGF-beta1
• The researchers' own stated conclusion was that "oral shilajit supplementation in adult healthy women induced genes relevant to endothelial cell migration and growth of blood vessels"
• No adverse effects were reported at 14 weeks

That trial is the basis of a real U.S. patent, number 11,077,045, granted in 2021 for using shilajit to improve skin microperfusion and switch on collagen-related genes.

What this study does and does not show

This is the section every skin claim about shilajit has to survive, honestly:

• The women in this trial had a mean age of 42 and the paper does not describe them as postmenopausal. It is a middle-aged women's study, not a postmenopausal one, and this article does not call it otherwise.
• The trial measured skin genes and blood flow, not wrinkle depth, firmness, or appearance. There is no before-and-after photo endpoint in this research at all.
• Elasticity, hydration, and water loss through the skin showed no difference between shilajit and placebo. That is a safety finding, not an efficacy win, and should never be read as the opposite.
• Only the higher, 250 mg twice-daily dose moved the blood flow measurement. The lower dose switched on the same genes without that effect.

A separate, earlier human trial by Das and colleagues in 2016 found something complementary in a different tissue. In 16 overweight adults taking shilajit for 8 weeks, muscle biopsies showed the gene for type I collagen running at roughly 86 times its baseline activity, alongside four other collagen types. Type I collagen is the same structural protein that makes up the bulk of skin's collagen network, so this is relevant systemic evidence of the body's collagen machinery responding to shilajit, even though that particular trial biopsied muscle tissue, not skin.

What does the research say about collagen supplements and creams?

The market for fixing collagen loss is enormous, and the evidence quality varies sharply by category. A fair side-by-side:

A scoop of collagen peptide is, chemically, building material. It gets broken down in digestion like any other protein and the body decides what to do with the amino acids. That is not a reason to call it useless, the peptide trials do show real, if modest, effects. It is a reason to separate "more raw material" from "a stronger signal to use it," which is a different question entirely.

What actually helps crepey skin, based on the evidence?

A few things have real research behind them, stated at the strength the evidence supports:

1. Consistent sun protection slows further collagen breakdown; UV exposure is a separate, additive driver of collagen loss on top of the hormonal one
2. Topical retinoids, used consistently over months, have the strongest dermatology-trial evidence for visibly increasing collagen synthesis
3. Resistance exercise has been shown in some research to support skin thickness indirectly, likely through improved circulation and connective tissue loading
4. Not smoking matters more than most people assume; smoking independently accelerates collagen breakdown through enzymes called matrix metalloproteinases
5. Adequate protein intake supports the raw material fibroblasts need, even though it does not supply the signal to use it

None of these reverse the structural collagen loss documented above. They slow it, support it, or work alongside it.

See Optimum Shilajit

Optimum Shilajit is built around the same collagen and estrogen-signaling research discussed in this article, including the placebo-controlled human skin study above. It has not been tested for wrinkle reduction or skin appearance, and this article makes no such claim. See Optimum Shilajit.

See See Optimum Shilajit